X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (47729) 47729
Newspaper Article (32123) 32123
Magazine Article (592) 592
Trade Publication Article (309) 309
Book Chapter (299) 299
Dissertation (271) 271
Web Resource (195) 195
Publication (79) 79
Conference Proceeding (48) 48
Book Review (39) 39
Newsletter (29) 29
Book / eBook (22) 22
Report (18) 18
Journal / eJournal (12) 12
Government Document (4) 4
Paper (2) 2
Data Set (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human papillomavirus (59612) 59612
cervical cancer (31822) 31822
humans (30140) 30140
female (22762) 22762
vaccines (17478) 17478
cancer (16648) 16648
oncology (13795) 13795
immunization (13711) 13711
adult (13140) 13140
middle aged (11323) 11323
womens health (11222) 11222
papillomavirus infections (9892) 9892
male (9040) 9040
human-papillomavirus (8996) 8996
women (7549) 7549
aged (6915) 6915
studies (6754) 6754
infections (6511) 6511
research (6187) 6187
medical screening (6177) 6177
risk factors (6130) 6130
hpv (6087) 6087
adolescent (5857) 5857
papillomavirus infections - virology (5685) 5685
uterine cervical neoplasms - virology (5661) 5661
health aspects (5633) 5633
prevalence (5585) 5585
medical research (5040) 5040
infection (4944) 4944
vaccination (4790) 4790
young adult (4620) 4620
papillomaviridae - genetics (4447) 4447
risk (4294) 4294
immunology (4266) 4266
papillomaviridae - isolation & purification (4240) 4240
dna (4186) 4186
infectious diseases (4127) 4127
squamous cell carcinoma (4059) 4059
analysis (3972) 3972
tumors (3960) 3960
squamous-cell carcinoma (3941) 3941
pathology (3872) 3872
deoxyribonucleic acid--dna (3846) 3846
diagnosis (3801) 3801
papillomavirus infections - complications (3755) 3755
papillomavirus infections - epidemiology (3706) 3706
uterine cervical neoplasms - pathology (3695) 3695
prevention (3642) 3642
polymerase chain reaction (3635) 3635
obstetrics & gynecology (3602) 3602
papillomavirus infections - prevention & control (3579) 3579
epidemiology (3575) 3575
public health (3440) 3440
viruses (3319) 3319
cervical-cancer (3311) 3311
expression (3278) 3278
cervix (3220) 3220
virology (3172) 3172
proteins (3170) 3170
papillomaviruses (3084) 3084
human-papillomavirus infection (3019) 3019
cervical intraepithelial neoplasia (2993) 2993
animals (2980) 2980
papillomavirus infections - diagnosis (2902) 2902
prognosis (2845) 2845
uterine cervical neoplasms - prevention & control (2811) 2811
medicine (2803) 2803
care and treatment (2798) 2798
research & development--r&d (2792) 2792
lesions (2749) 2749
carcinoma, squamous cell - virology (2731) 2731
public, environmental & occupational health (2718) 2718
surgery (2677) 2677
medicine, research & experimental (2662) 2662
head (2645) 2645
carcinoma (2640) 2640
aged, 80 and over (2639) 2639
intraepithelial neoplasia (2633) 2633
uterine cervical neoplasms - diagnosis (2625) 2625
carcinoma, squamous cell - pathology (2565) 2565
cancer therapies (2542) 2542
dna, viral - analysis (2519) 2519
human papilloma virus (2405) 2405
immunohistochemistry (2392) 2392
patients (2390) 2390
cervical intraepithelial neoplasia - virology (2352) 2352
research article (2317) 2317
genotype (2313) 2313
gene expression (2312) 2312
age (2310) 2310
immunotherapy (2301) 2301
clinical trials (2286) 2286
cytology (2266) 2266
health risk assessment (2240) 2240
human-papillomavirus type-16 (2229) 2229
uterine cervical neoplasms - epidemiology (2145) 2145
survival (2133) 2133
genetic aspects (2121) 2121
papillomavirus infections - pathology (2119) 2119
virus diseases (2101) 2101
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (10) 10
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Online Resources - Online (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
New College (Ivey) - Stacks (1) 1
Robarts - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (79022) 79022
German (573) 573
Chinese (562) 562
Spanish (527) 527
French (483) 483
Japanese (215) 215
Korean (189) 189
Portuguese (179) 179
Russian (155) 155
Polish (59) 59
Turkish (48) 48
Italian (41) 41
Czech (32) 32
Hungarian (18) 18
Persian (16) 16
Swedish (14) 14
Croatian (7) 7
Breton (6) 6
Bulgarian (6) 6
Serbian (6) 6
Danish (5) 5
Dutch (4) 4
Romanian (4) 4
Slovak (4) 4
Slovenian (4) 4
Hindi (3) 3
Lithuanian (3) 3
Afrikaans (2) 2
Estonian (2) 2
Icelandic (2) 2
Norwegian (2) 2
Ukrainian (2) 2
Urdu (2) 2
Arabic (1) 1
Bosnian (1) 1
Gaelic (1) 1
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2013, Volume 382, Issue 9895, pp. 889 - 899
Summary Cervical cancer is caused by human papillomavirus infection. Most human papillomavirus infection is harmless and clears spontaneously but persistent... 
Internal Medicine | WOMEN | POPULATION | MEDICINE, GENERAL & INTERNAL | PERSISTENCE | DNA | VACCINE | HPV INFECTION | FOLLOW-UP | RISK | CYTOLOGY | INTRAEPITHELIAL NEOPLASIA | Human papillomavirus 18 - immunology | Human papillomavirus 6 - immunology | Humans | Uterine Cervical Neoplasms - epidemiology | Human papillomavirus 11 - ultrastructure | Uterine Cervical Neoplasms - pathology | Human papillomavirus 16 - immunology | Human papillomavirus 6 - ultrastructure | Papillomavirus Infections - pathology | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Human papillomavirus 11 - immunology | Human papillomavirus 16 - ultrastructure | Human papillomavirus 11 - pathogenicity | Papillomavirus Vaccines - administration & dosage | Human papillomavirus 6 - pathogenicity | Human papillomavirus 16 - pathogenicity | Cross-Sectional Studies | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Vaginal Smears | Mass Screening | Virus Replication | Human papillomavirus 18 - pathogenicity | Papillomavirus Infections - prevention & control | Uterine Cervical Neoplasms - virology | Human papillomavirus 18 - ultrastructure | Papillomavirus Vaccines - immunology | Developing Countries | Cell Transformation, Neoplastic - pathology | Cell Transformation, Viral | Prevention | Papillomaviruses | Usage | Vaccines | Properties | Papillomavirus infections | Risk factors | Cervical cancer | Studies | Human papillomavirus | Immunization | Cellular biology | Womens health | Medical screening | Epidemiology | Age
Journal Article
International journal of cancer, ISSN 0020-7136, 2016, Volume 138, Issue 11, pp. 2745 - 2751
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 365, Issue 17, pp. 1576 - 1585
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2013, Volume 8, Issue 7, p. e68379
Human papillomavirus (HPV) infection is the leading cause of cervical cancer world-wide. Here, we show that native HPV particles produced in a differentiated... 
DNA | MULTIDISCIPLINARY SCIENCES | RECEPTOR | HEPARAN-SULFATE | EXTRACELLULAR-MATRIX | CERVICAL-CANCER | MINOR CAPSID PROTEIN | HUMAN-PAPILLOMAVIRUS INFECTION | HUMAN KERATINOCYTES | SURFACE-BINDING | Chlorates - pharmacology | Human papillomavirus 18 - growth & development | Keratinocytes - virology | Species Specificity | Humans | Human papillomavirus 16 - drug effects | Human papillomavirus 16 - growth & development | Virus Internalization - drug effects | Carrageenan - pharmacology | Human papillomavirus 18 - metabolism | Female | Heparin - pharmacology | Cell Line | Virus Replication - drug effects | Glycosaminoglycans - metabolism | Human papillomavirus 31 - drug effects | Keratinocytes - cytology | Human papillomavirus 31 - growth & development | Glycosaminoglycans - deficiency | Human papillomavirus 16 - metabolism | Virus Attachment - drug effects | Human papillomavirus 31 - metabolism | Keratinocytes - drug effects | Human papillomavirus 18 - drug effects | Virus Replication - physiology | Usage | Glycosaminoglycans | Development and progression | Research | Papillomavirus infections | Health aspects | Risk factors | Heparan sulfate | Epithelial cells | Keratinocytes | Particulates | Viruses | Infections | Genomes | Vaccines | Cervix | Epithelium | Virology | Proteins | Human papillomavirus | Immunology | Gag protein | Extracellular matrix | Carrageenan | Cervical cancer | Cancer
Journal Article
PloS one, ISSN 1932-6203, 2012, Volume 7, Issue 11, p. e48972
Human papillomaviruses (HPV) are classified into high-risk HPV and low-risk HPV. The most common high-risk HPV types in cervical cancer are HPV 16 and 18, and... 
VIRAL LOAD | WOMEN | IMMUNOGENICITY | ASSAY | HIGH-RISK | RT-PCR | MULTIDISCIPLINARY SCIENCES | HPV VACCINE | INFECTION | PREVALENCE | INTRAEPITHELIAL NEOPLASIA | Temperature | Human papillomavirus 11 - classification | Human papillomavirus 16 - classification | Humans | Human papillomavirus 6 - genetics | Real-Time Polymerase Chain Reaction - methods | DNA Probes - chemistry | DNA Primers - chemistry | Human papillomavirus 6 - classification | Papillomaviridae - genetics | Papillomavirus Infections - diagnosis | Human papillomavirus 16 - isolation & purification | Reference Standards | Sensitivity and Specificity | Human papillomavirus 18 - genetics | Human papillomavirus 11 - isolation & purification | Multiplex Polymerase Chain Reaction - methods | Reproducibility of Results | Human papillomavirus 6 - isolation & purification | Genotype | Papillomaviridae - isolation & purification | Human papillomavirus 11 - genetics | Human papillomavirus 18 - isolation & purification | Papillomaviridae - classification | Human papillomavirus 18 - classification | Human papillomavirus 16 - genetics | Polymerase chain reaction | Warts | Genetic aspects | Health aspects | Papillomavirus infections | Cervical cancer | Correlation coefficient | Laboratories | Correlation coefficients | Health risks | Fluorescence | Viruses | Risk | Fluorescent indicators | Cervix | Sensitivity | Human papillomavirus | Plasmids | Reproducibility | Genotypes
Journal Article
Virology, ISSN 0042-6822, 2010, Volume 405, Issue 1, pp. 31 - 40
Journal Article
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 30, Issue 37, pp. 5496 - 5499
Journal Article
PloS one, ISSN 1932-6203, 2013, Volume 8, Issue 4, p. e60696
Background: To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection dynamics in the Netherlands, we started an ongoing study in... 
UNITED-STATES | WOMEN | IMPACT | AUSTRALIA | MULTIDISCIPLINARY SCIENCES | MEN | VACCINATION | TYPE-16 | SEROPREVALENCE | CANCER | HPV TYPES | Antibody Specificity | Human papillomavirus 18 - immunology | Human papillomavirus 16 - physiology | Heterosexuality | Humans | Genitalia, Female - virology | Male | Human papillomavirus 16 - immunology | Anal Canal - virology | Antibodies, Viral - blood | Papillomavirus Infections - blood | Young Adult | Human papillomavirus 16 - isolation & purification | Homosexuality, Male | Female | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | Child | Human papillomavirus 18 - physiology | Genotype | Organ Specificity | DNA, Viral - blood | Human papillomavirus 18 - isolation & purification | Adolescent | Antibodies, Viral - immunology | DNA, Viral - genetics | Genitalia, Male - virology | Human papillomavirus 16 - genetics | Papillomaviruses | Viral antibodies | Medical research | Sexually transmitted diseases | Analysis | DNA | Medicine, Experimental | Antibodies | Vaccines | Health aspects | Papillomavirus infections | Risk factors | Sexually transmitted diseases--STD | Homology | Infections | Gender | Males | Epidemiology | Mens health | Carcinogens | Human papillomavirus | Questionnaires | Population | Mathematical models | Public health | Deoxyribonucleic acid--DNA | Young adults | Clinics | Sexual behavior | Risk taking | Regression analysis | Risk analysis | Disease control | Infectious diseases | Womens health | Men | Females | Cancer | STD | Deoxyribonucleic acid
Journal Article
Journal Article